Abstract:Ferritin iron from food is readily bioavailable to humans and has the potential for treating iron deficiency. Whether ferritin iron absorption is mechanistically different from iron absorption from small iron complexes/salts remains controversial. Here, we studied iron absorption (RBC 59 Fe) from radiolabeled ferritin iron (0.5 mg) in healthy women with or without nonferritin iron competitors, ferrous sulfate, or hemoglobin. A 9-fold excess of non-ferritin iron competitor had no significant effect on ferritin … Show more
“…28,29 Ironcarrying proteins like ferritin from food are efficiently absorbed without depending on reduction or the heme transporter via receptor-mediated, clathrin-dependent endocytosis. 30 Absorption and increased iron accumulation were also found in the liver, when Fe(II) was ingested with glycine and asparagine, but not with other amino acids. 31 Once in the cell, iron is exported by ferroportin 1, also known as IREG1, MTP1, SLC40A1, FPN1, and HFE4, into the circulation.…”
Atopic individuals tend to develop a Th2 dominant immune response, resulting in hyperresponsiveness to harmless antigens, termed allergens. In the last decade, epidemiological studies have emerged that connected allergy with a deficient iron-status. Immune activation under iron-deficient conditions results in the expansion of Th2-, but not Th1 cells, can induce class-switching in B-cells and hampers the proper activation of M2, but not M1 macrophages. Moreover, many allergens, in particular with the lipocalin and lipocalin-like folds, seem to be capable of binding iron indirectly via siderophores harboring catechol moieties. The resulting locally restricted iron-deficiency may then lead during immune activation to the generation of Th2-cells and thus prepare for allergic sensitization. Moreover, iron-chelators seem to also influence clinical reactivity: mast cells accumulate iron before degranulation and seem to respond differently depending on the type of the encountered siderophore. Whereas deferoxamine triggers degranulation of connective tissue-type mast cells, catechol-based siderophores reduce activation and degranulation and improve clinical symptoms. Considering the complex interplay of iron, siderophores and immune molecules, it remains to be determined whether iron-deficiencies are the cause or the result of allergy.
“…28,29 Ironcarrying proteins like ferritin from food are efficiently absorbed without depending on reduction or the heme transporter via receptor-mediated, clathrin-dependent endocytosis. 30 Absorption and increased iron accumulation were also found in the liver, when Fe(II) was ingested with glycine and asparagine, but not with other amino acids. 31 Once in the cell, iron is exported by ferroportin 1, also known as IREG1, MTP1, SLC40A1, FPN1, and HFE4, into the circulation.…”
Atopic individuals tend to develop a Th2 dominant immune response, resulting in hyperresponsiveness to harmless antigens, termed allergens. In the last decade, epidemiological studies have emerged that connected allergy with a deficient iron-status. Immune activation under iron-deficient conditions results in the expansion of Th2-, but not Th1 cells, can induce class-switching in B-cells and hampers the proper activation of M2, but not M1 macrophages. Moreover, many allergens, in particular with the lipocalin and lipocalin-like folds, seem to be capable of binding iron indirectly via siderophores harboring catechol moieties. The resulting locally restricted iron-deficiency may then lead during immune activation to the generation of Th2-cells and thus prepare for allergic sensitization. Moreover, iron-chelators seem to also influence clinical reactivity: mast cells accumulate iron before degranulation and seem to respond differently depending on the type of the encountered siderophore. Whereas deferoxamine triggers degranulation of connective tissue-type mast cells, catechol-based siderophores reduce activation and degranulation and improve clinical symptoms. Considering the complex interplay of iron, siderophores and immune molecules, it remains to be determined whether iron-deficiencies are the cause or the result of allergy.
“…The acid environment of the stomach and exposure to digestive enzymes cause a partial release of these iron forms from the digestate. Heme and non-heme iron appear to be absorbed by separate mechanisms (266), and there may be yet another pathway involved in ferritin absorption (241). Despite the importance of heme and ferritin as dietary sources of iron, and despite some promising leads (196,222,241), little is known about their transport and metabolism in the enterocyte.…”
Section: A Tissues Cells and Fluxesmentioning
confidence: 99%
“…Duodenal iron absorption requires that iron cross the apical membrane, followed by variable storage in cytoplasmic ferritin, then iron transport across the enterocyte and the transfer of iron across the basolateral membrane. Much evidence, especially the consequences of genetic disorders and mouse mutations that disable basolateral iron export, indicates that iron from ferritin or heme exits the enterocyte by the same route, i.e., that iron of heme and ferritin must be liberated in the absorptive endosome or in the cytoplasm (241,266). Thus no matter how it is taken up by the enterocyte, iron in its ferric form is delivered to plasma transferrin near the basolateral surface.…”
The iron hormone hepcidin and its receptor and cellular iron exporter ferroportin control the major fluxes of iron into blood plasma: intestinal iron absorption, the delivery of recycled iron from macrophages, and the release of stored iron from hepatocytes. Because iron losses are comparatively very small, iron absorption and its regulation by hepcidin and ferroportin determine total body iron content. Hepcidin is in turn feedback-regulated by plasma iron concentration and iron stores, and negatively regulated by the activity of erythrocyte precursors, the dominant consumers of iron. Hepcidin and ferroportin also play a role in host defense and inflammation, and hepcidin synthesis is induced by inflammatory signals including interleukin-6 and activin B. This review summarizes and discusses recent progress in molecular characterization of systemic iron homeostasis and its disorders, and identifies areas for further investigation.
“…12 Although the mechanisms for uptake of dietary heme and ferritin are less well understood, evidence suggests that iron is subsequently liberated and enters a common pathway as inorganic iron in the enterocyte. 13,14 Iron taken up by enterocytes can be used directly for intrinsic cellular metabolic processes, stored, or exported across the basolateral membrane for systemic delivery. Iron is stored in enterocytes, like other cells, largely in the form of ferritin, which is comprised of a spherical nanocage of heavy (H) and light (L) chains surrounding a core of iron that is oxidized by H-ferritin.…”
Iron is an essential element for numerous fundamental biologic processes, but excess iron is toxic. Abnormalities in systemic iron balance are common in patients with chronic kidney disease (CKD) and iron administration is a mainstay of anemia management in many patients. This review provides an overview of the essential role of iron in biology, the regulation of systemic and cellular iron homeostasis, how imbalances in iron homeostasis contribute to disease, and the implications for CKD patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.